-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PZ+/5TaJ0OiS4aG8RQDTqLTONGWbjBOxOifz+AEEyQ/3GSMKZc52aNh9EUMq3h0D FqobC72vPXghLe6LMnSOAA== 0001140361-10-025859.txt : 20100617 0001140361-10-025859.hdr.sgml : 20100617 20100617161407 ACCESSION NUMBER: 0001140361-10-025859 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100615 FILED AS OF DATE: 20100617 DATE AS OF CHANGE: 20100617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCHENRY GEORGE E JR CENTRAL INDEX KEY: 0000938838 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 10903370 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0303 4 2010-06-15 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0000938838 MCHENRY GEORGE E JR TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 0 1 0 0 Executive Vice President, CFO Common Stock 2010-06-15 4 S 0 8750 16.7936 D 65565 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 40000 40000 D Option to Buy 16.74 2003-10-15 2012-10-14 Common Stock 75000 75000 D Option to Buy 5.50 2002-10-15 2011-10-14 Common Stock 56000 56000 D These shares were sold at a range of sale prices from $16.66 to $17.14. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 5,500 shares of stock from an initial grant of 5,500 shares of restricted stock made on March 30, 2010; (ii) unvested restricted shares that total 17,010 shares of stock from an initial grant of 22,680 shares of restricted stock and performance shares made on November 13, 2008; (iii) unvested restricted shares and fully vested shares that total 31,349 shares of stock from an initial grant of 40,000 shares of restricted stock and performance shares made on August 9, 2007; and (iv) fully vested shares that total 11,706 shares of stock from an initial grant of 35,000 shares of restricted stock made on June 12, 2006. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option is fully vested. /s/ Teri L. Champ, Attorney-in-Fact for George E. McHenry, Jr. 2010-06-17 -----END PRIVACY-ENHANCED MESSAGE-----